Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2019-03-06 Investor Presentation
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
关于举行2018年度网上业绩说明会的通知
Investor Presentation Classification · 95% confidence The document is a notice about holding an online performance explanation meeting (业绩说明会) related to the 2018 annual report, scheduled for March 12, 2019. It references that the 2018 annual report was disclosed on February 28, 2019, and invites investors to participate in the online meeting to further understand the annual report and company operations. The document is short (644 characters) and serves as an announcement for an event related to the annual report, not the report itself. Therefore, it fits the category of Investor Presentation (IP) since it is about a detailed presentation for investors focusing on financials and company performance, rather than the Annual Report (10-K) itself or a Report Publication Announcement (RPA).
2019-03-06 Chinese
关于公司获得《药品GMP证书》的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement about receiving a GMP certificate from a regulatory authority. It is a formal disclosure but does not contain financial data, management changes, voting results, or any report publication. It is a regulatory announcement related to compliance and certification. The document length is short and it is not a report or financial statement. Therefore, it fits best under Regulatory Filings (RNS).
2019-03-05 Chinese
关于全资子公司获得高新技术企业证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about its wholly-owned subsidiary receiving a high-tech enterprise certificate, including details about tax benefits and certification validity. It does not contain financial statements, management discussion, or detailed report content. It is an official company announcement about a specific event or status update, not a financial report or regulatory filing. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2019-03-04 Chinese
2018年度独立董事述职报告（卢北京）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Report" for the year 2018 by a specific independent director of the company. It details the director's attendance at board meetings and shareholder meetings, opinions expressed on various company matters, committee work, investigations conducted, and efforts to protect shareholder rights. The content is a narrative report on the director's duties and activities during the year rather than a financial report, audit, or regulatory filing. It is not an annual report, audit report, earnings release, or any other financial statement. It is also not a short announcement or certification but a substantive report by a board member. This type of document fits best under Board/Management Information (MANG), which includes announcements or reports related to board members and senior management activities and changes. The document length (3086 characters) and detailed content support this classification with high confidence.
2019-02-27 Chinese
2018年年度报告
Annual Report Classification · 100% confidence The document is titled "2018 年年度报告" which translates to "2018 Annual Report". It contains detailed sections typical of an annual report such as company overview, financial data, business summary, management discussion and analysis, corporate governance, and financial statements. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. It includes audited financial data, management statements, and comprehensive business and financial analysis for the fiscal year 2018. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2018
2019-02-27 Chinese
国信证券股份有限公司关于公司内部控制规则落实自查表的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from Guosen Securities Co., Ltd. regarding the internal control rules implementation self-check form of Te Yi Pharmaceutical Group Co., Ltd. It references regulatory guidelines related to securities issuance and listing sponsorship, and the Shenzhen Stock Exchange internal control rules. The document is short (802 characters) and primarily contains an attestation or certification by the sponsoring institution about the accuracy and completeness of the internal control self-check form. There are no financial statements, detailed financial data, or comprehensive reports included. This fits the criteria for a Regulatory Filing (RNS) as it is a compliance-related certification rather than a full report or announcement of a report publication.
2019-02-27 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.